His scientific interests lie mostly in Dementia, Alzheimer's disease, Internal medicine, Gerontology and Cognition. His studies in Dementia integrate themes in fields like Psychiatry, Cohort study and Pediatrics. His research integrates issues of Genetics, Genome-wide association study and Central nervous system disease, Neuroscience, Degenerative disease in his study of Alzheimer's disease.
The various areas that Oscar L. Lopez examines in his Internal medicine study include Endocrinology and Cardiology. His Gerontology research incorporates themes from Hyperintensity, Cohort and Risk factor. His study in Cognition is interdisciplinary in nature, drawing from both Odds ratio, Physical therapy, Magnetic resonance imaging and Randomized controlled trial.
Oscar L. Lopez spends much of his time researching Dementia, Internal medicine, Disease, Alzheimer's disease and Cognition. Oscar L. Lopez has included themes like Psychiatry, Pediatrics and Gerontology in his Dementia study. Oscar L. Lopez combines subjects such as Endocrinology, Hyperintensity, Oncology and Cardiology with his study of Internal medicine.
His Disease research includes themes of Genetics, Clinical trial, Incidence, Stroke and Vascular disease. His Alzheimer's disease research incorporates elements of Genome-wide association study, Central nervous system disease, Neuroscience, Degenerative disease and Psychosis. His Cognition research is multidisciplinary, incorporating elements of Cardiovascular health, Audiology and Clinical psychology.
Oscar L. Lopez mostly deals with Dementia, Internal medicine, Disease, Cognition and Cognitive decline. He has researched Dementia in several fields, including Hyperintensity, Epidemiology, Cardiovascular health, Confidence interval and Alzheimer's disease. His work carried out in the field of Alzheimer's disease brings together such families of science as Biomarker, Psychosis and Genetic association.
The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Oncology and Cardiology. His Disease research integrates issues from Clinical trial, Incidence, Systemic inflammation and Cohort. His biological study spans a wide range of topics, including Evolutionary biology, Gerontology, Pediatrics and MEDLINE.
The scientist’s investigation covers issues in Dementia, Internal medicine, Cognition, Disease and Cognitive decline. The various areas that Oscar L. Lopez examines in his Dementia study include Biomarker, Epidemiology, Incidence, Alzheimer's disease and Cohort. His Alzheimer's disease research includes elements of Genetics, Atrophy, CADASIL, Genetic association and Executive functions.
His Internal medicine research is multidisciplinary, incorporating elements of Endocrinology, Mri scan and Plasmapheresis. His Cognition research integrates issues from Evolutionary biology, Activities of daily living, Pediatrics and Cortex. The study incorporates disciplines such as Genetic heterogeneity, Biobank and Heritability in addition to Disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Jean-Charles Lambert;Jean-Charles Lambert;Jean-Charles Lambert;Carla A Ibrahim-Verbaas;Denise Harold;Adam C Naj.
Nature Genetics (2013)
Vascular Contributions to Cognitive Impairment and Dementia A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
Philip B. Gorelick;Angelo Scuteri;Sandra E. Black;Charles Decarli.
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
Constantine G. Lyketsos;Oscar Lopez;Beverly Jones;Annette L. Fitzpatrick.
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory
Daniel I. Kaufer;Jeffrey L. Cummings;Jeffrey L. Cummings;Patrick Ketchel;Patrick Ketchel;Vanessa Smith;Vanessa Smith.
Journal of Neuropsychiatry and Clinical Neurosciences (2000)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
Valentina Escott-Price;Céline Bellenguez;Li-San Wang;Seung-Hoan Choi.
PLOS ONE (2014)
Genome-wide analysis of genetic loci associated with Alzheimer disease.
Sudha Seshadri;Annette L. Fitzpatrick;M Arfan Ikram;Anita L. DeStefano.
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Ronald C. Petersen;Oscar Lopez;Melissa J. Armstrong;Thomas S.D. Getchius.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: